In the same vein, in vivo xenograft revealed how the enhanced tumor growth induced by Ang II was reversed by an inhibitor of aromatase such as Anastrozole; however, the combined treatment of Losartan (LOS) and Anastrazole (ANA) upon angiotensin exposure dramatically reduced tumor volume bringing it below the control value. This evidence concerns the gene CYP19A1 and neoplasm.